← Eichor
Condition: De Novo Coronary Lesions Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: De Novo Coronary Lesions

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Advanced NanoTherapies Dual-API DCB to Treat De-Novo and ISR Lesions in Patients With Symptomatic Coronary Artery Diseas
NA · 3 location(s) · Advanced NanoTherapies · NCT07368933Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions
NA · 1 location(s) · Xijing Hospital · NCT07022587MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
NA · 24 location(s) · Concept Medical Inc. · NCT06271590Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With
NA · 14 location(s) · Biotronik AG · NCT07091682Leave Nothing Behind Study Which Compares DCB With Bail Out BRS Versus BRS Strategy Alone
NA · 1 location(s) · Ceric Sàrl · NCT07038408Ticin for the Treatment of Coronary Lesions With Drug Eluting Ballons
Phase 4 · 1 location(s) · Cardiocentro Ticino · NCT05674630Randomised Trial of Dual Device Treatment Involving Drug-coated Balloon Angioplasty and Drug-eluting Stent Implantation
NA · 1 location(s) · Royal College of Surgeons, Ireland · NCT07303439Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding R
NA · 18 location(s) · Samsung Medical Center · NCT06742931Multicenter Randomised Prospective Study for External Support Mesh VEST of Venous Coronary Grafts on the Right Territory
NA · 1 location(s) · Cardiochirurgia E.H. · NCT06877195Drug-Coated Coronary Balloons in Different Clinical Scenarios
Phase N/A · 5 location(s) · Kutahya Health Sciences University · NCT06915597STabilization of Atheroma by Lipid-reducing Effect of Drug-Coated Balloon (STABLE-DCB)
Phase N/A · 1 location(s) · Korea University Ansan Hospital · NCT05438121Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for De Novo Coronary Bifurcation Lesions
NA · 1 location(s) · BrosMed Medical Co., Ltd · NCT06822712Impact of Drug-coated Balloon Treatment in de Novo Coronary Lesion
Phase N/A · 1 location(s) · Ulsan Medical Center · NCT04619277AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous
NA · 62 location(s) · Boston Scientific Corporation · NCT06959524Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Les
NA · 18 location(s) · The First Affiliated Hospital of Zhengzhou University · NCT07463664Drug-Coated Balloon Primary PCI in ST-Segment Elevation Myocardial Infarction
Phase N/A · 1 location(s) · Medical University of Vienna · NCT07436429Prevail Global Study
NA · 51 location(s) · Medtronic Vascular · NCT06535854Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions
NA · 8 location(s) · Chonnam National University Hospital · NCT06954714SELUTION 4 De Novo Small Vessel IDE Trial
NA · 70 location(s) · M.A. Med Alliance S.A. · NCT05946629Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both
NA · 18 location(s) · Fundación EPIC · NCT07190690Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Ar
NA · 2 location(s) · Teleflex · NCT07258290SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective
NA · 10 location(s) · Fondazione Evidence per Attività e Ricerche Cardiovascolari · NCT06373601
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.